In this section, you can add new consortium or search for partners or R&D&i project proposals in Animal Health that are already defined or in their initial stage. The scope of the projects can be national, European or international calls, or private projects.
Development of reliable recombinant vaccine against photobacteriosis in gilthead seabream, Sparus aurata. The outcome of the research project should be a viable commercial product or technique.
Gilt-head seabream, Sparus aurata,is one of the most reared fish in worldwide aquaculture and is highly appreciated as food fish in the area of Arabian Gulf. In this area, photobacteriosis is causing severe losses and mortalities up to 50% in the cultured seabream, especially when the fish weight is 50-70 g. Development of a reliable vaccine against photobacteriosis infection in gilt-head seabream using recombinant DNA technology is urgently needed, not only in Arabian Gulf area, but also worldwide.
Company name: Fujairah Research Center
Contact person and title/ designation: Dr. Nabil Mansour. Head of Research
E-mail: nabil.mansour@frc.ae
Phone number: +9719 222 2808
Mobile number: +971503924790
Website: www.frc.ae
The IES Antonio Machado requests places of FCT (Training in Work Centers) in laboratories, so that the students of the Higher Training Cycle of
Pathological Anatomy and Cytodiagnosis, can carry out compulsory and unpaid end-of-cycle internships and obtain the corresponding Higher Technician degree.
These practices are carried out in the period from mid-March to June, or in the period from September to December, students are tutored and perform the usual laboratory tasks.
Contact:
Sara Escudero. FCT-APC tutor.
IES Antonio Machado. C/Alalpardo s/n. Alcala de Henares, 28806.
Telephone: 918892450, ext. 127
Mail: apc@iesmachado.org
Startup based in Barcelona, we are looking to find a partner in a study on the leishmanicidal efficacy of a new product on the market. It is a molecule that has been shown to be effective in in vitro studies, and a clear effect has been determined in patients in whom the product was tested. In addition, this molecule is an immune stimulator, which makes it a strong candidate for an innovative treatment of this parasitic disease.
The project is defined and only part of the financing is missing. In the case of being interested, we would explain in depth what it consists of and we would open a collaboration window according to the interests of the partner.
For more information, you can contact me directly: Lourdes 660587453
The overarching goal of the project is to define, validate and apply a standardised workflow (experimental and computational) for deriving reliable human reference points and HBGVs using cutting edge in-vitro approaches, namely organ-on-a-chip (OoC) platforms and multiple OMICs endpoints (transcriptomics, metabolomics, epigenomics).
Estimated total value 3.250.000.00 euros.
Time limit for receipt of tenders 15/06/2022.
If you are interested in this collaboration opportunity, please contact Ludovic Lehegarat through the email address: Ludovic.lehegarat@anses.fr
Quantix Innovation Group is a technology innovation group with a strong focus on research, development, innovation and a focus on digital products, software as a service and digital technologies for business, where we apply, for example, in the agricultural sector and is materialized through the startup ´Agrónomo Digital´. This startup is specialized in the development of software and digital technologies applied to the agricultural sector.
The Agrônomo Digital project was presented at BraFIP`s Incoday 2021 event, held in Brazil, where Brazilian and Spanish companies had the opportunity to present international collaboration initiatives.
As for the product, it is a platform that in the future aims to provide numerous essential services for farms, where the initial focus for the moment is on the diagnostic service and recommendations for phytosanitary and nutritional treatments.
Contact: Henrique (+55 11 88088 8753) henrique.trindade@grupoquantix.com.br
More information on this link.
ICEX Spain Export and Investment, together with the Economic and Commercial Office of Spain in Algiers organizes MISSION DIRECT ALGERIA 2022: Equipment for aquaculture and fish processing to be held on 30/05/2022 01/06/2022.
Organized by ICEX Spain Export and Investment and the Economic and Commercial Office in Algiers with the aim of Spanish companies to develop meetings with potential customers, partners and collaborators in Algeria.
Individual and personalized agendas to meet with potential partners and clients.
More information in https://www.icex.es/icex/es/navegacion-principal/todos-nuestros-servicios/visitar-mercados/agenda/SEM2022898962.html
ICEX Spain Export and Investment, in collaboration with the Economic and Commercial Office of Spain in Moscow, convenes a Prospecting Mission of technology and industrial equipment for the fishing / fish processing and aquaculture sectors in the Russian city of Vladivostok with the following objectives:
Where:
The event will be held in the city of Vladivostok, a Russian port city located in the Russian Far East, capital of the Far Eastern Federal District and administrative center of Primorye Krai. The city is located very close to the Russian border with China and North Korea, 9,302 km from Moscow and is the most important Russian port on the Pacific Ocean.
The SILPROVET project plans to respond to the market´s necessity, proposing an alternative to both antibiotics and ZnO in, but not restricted to, the pig production industry. SILPROVET employs a highly innovative patented technology based on the use of silver nanoparticles. This solution provides a better antimicrobial action than other alternatives, as well as a very low cytotoxicity. Additionally, the nanoparticle technology used enables a reduction in dosage, reducing toxicity and side effects. Apart from being an environmentally friendly product, these characteristics make SILPROVET a very promising technology platform as a new class of veterinary antimicrobial in substitution of antibiotics and ZnO (permitted use until June 2022).
The search for a partner is launched by the company, of Egyptian origin, Si-Ware Systems, which has the NeoSpectra spectrometer, one of the smallest on the market and with various applications such as identification of raw materials, food adulteration or feed testing agricultural.
The purpose of the proposal is to be submitted to the call for R&D, launched by CDTI, International Technological Cooperation Projects with UNILATERAL certification and monitoring. To participate you need at least one Spanish company and one Egyptian company. The call is currently open and allows the submission of proposals until the end of 2021.
For more information about the proposal, contact directly the Vice President of Global Development of the company Si-Ware Systems, Mr. Emad Eskandar, Emad.eskandar@si-ware.com
The objective of this call is to identify the organizations, which can be entrusted with the tasks detailed in the following three batches, once the Framework Association Agreements (FPA) have been concluded with a duration of up to 4 years:
The deadline for submitting proposals is Friday, June 25, 2021.
More details on the main and specific objectives in the call documents and the call documents can be found here.
A company founded in 2017 is looking for partners with whom it can establish a collaboration by providing a layer of value through technologies related to metagenomic or genomic analysis. The kind of
projects in which the company can contribute its experience include: preclinical trials (mouse, rat and other rodents model), animal experimentation trials (vaccines, feeding, use of food additives, studies related to productivity, epidemiological) including porcine model, avian, ovine and bovine.
For more information, contact BIOVEGEN: Gonzaga Ruiz de Gauna (gruizgauna@invegen.org)
Technology-based company founded in 2017 is looking for a partner that can provide strains of the genus Eimeria for use in infection models in poultry. Specifically, the company is especially interested in the following strains: E. acervulina, E.tenella, E.maxima
We are looking for a partner that can act as a CRO-Contract Research Organization in the production of these three strains or others of the same genus for studies of infection in animals (broilers, broilers for coccidiosis tests).
For more information, contact BIOVEGEN: Gonzaga Ruiz de Gauna (gruizgauna@invegen.org)
It is an international project with a Malaysian company and university in the detection of zoonotic pathogens transmitted by food and the development of a rapid test kit. In addition to the detection of pathogens, the ultimate goal is to develop a rapid test kit that can be used, for example, in the market where these animals are sold as food for human consumption.
Project idea raised by: Medical Biotechnology Group, Department of Biotechnology, International Islamic University of Malaysia, and industrial partner IKOP Sdn. Bhd
For more information you can contact: malasia@cdti.e
IRNASA is looking for companies to form a flexible consortium that allows the project to be submitted to different calls for funding.
Objectives:
1. Development of the detection of drugs for animal use in soil and water by UHPLC / MS.
2. Mapping the levels of contamination by animal drugs in lands and aquifers dedicated to organic farming.
3. Search and characterization of bacteria of the edaphic biota that degrade said drugs, to include them as a supplement in biofertilizers.
Interested parties, contact the following emails: direccion.irnasa@csic.es and jorge.cabero@fgcsic.es
IRNASA is looking for companies to form a flexible consortium that allows the project to be submitted to different calls for funding.
Objectives:
1. Isolation and identification of helminth-derived antiviral and anti-inflammatory compounds in in vitro and in vivo models.
2. Characterization of the most promising compounds.
3. Production and validation of new antiviral and anti-inflammatory drugs.
Interested parties, contact the following emails: direccion.irnasa@csic.es and jorge.cabero@fgcsic.es
IRNASA is looking for companies to form a flexible consortium that allows the project to be submitted to different calls for funding.
Objectives:
- Development of surveillance programs, predictive epidemiological models and identification of risk factors, especially the presence of vectors, responsible for the transmission of a large number of diseases.
- Promote early detection. Focus actions towards greater prevention and the development of diagnostic tools that enable a rapid response to emerging threats.
- Development of technological solutions and novel approaches in vaccine design.
- New non-polluting and sustainable treatments with the environment.
Interested parties, contact the following emails: direccion.irnasa@csic.es and jorge.cabero@fgcsic.es
For one of their drugs, they are looking for a manufacturer who can produce sterile gel. The sterile gel has to be in an aluminium tube. The three main criteria are:
- sterile gel
- packaging: tube in aluminium (75 grams)
- GMP (good manufacturing practices) / veterinary grade.
For this drug, the French company has the marketing authorization file approved by the competent authorities. A manufacturing agreement is sought to produce the drug according to the good manufacturing practices (GMP).
More information in this link.
We are looking for a Spanish company specialized in the development of Artificial Intelligence for a bilateral Spanish-Egyptian R&D project. On the part of Egypt, the consortium already has the company MicroHard for Technological Development. In this link you can find all the information for this partner search.
The activities planned in the project require:
The purpose of the proposal is to be presented to the bilateral ESITIP call between CDTI and ITIDA, which will be open until March 25, 2021.
For additional information about the project contact microcol@gmail.com
The company Team Foods Colombia S.A. (Alianza Team) is interested in collaborating with Spanish companies within the scope of R&D projects, with the aim of developing bioactive nutraceutical compositions with healthy benefits.
The desired profile of the foreign technology partner must meet these requirements:
More information: in this link.
Queries and submission of the completed form: colombia@cdti.es
The project is focused at “Obtention and valorization of natural bioactive extracts from agrifood residues”.
The proposal currently involves several companies and research centers both from Spanish agrifood sector. We are looking for European companies interested in joining the consortium and working in the following fields:
- Agrifood waste suppliers-companies from:
- Bioactive extracts users-companies from:
Interested entities can contact BIOVEGEN: gruizgauna@invegen.org
CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates.
Aiming to measure the immune response to different vaccines in development against SARS-CoV-2 in a single centralized laboratory, avoiding variability, the Coalition for Outbreak Preparedness Innovations (CEPI) is looking for laboratories around the world that are related to SARS-CoV-2 vaccines, able to carry out comparative studies or have the capacity to quickly transfer technology test from other laboratories.
Applications by email (centralizedlab@cepi.net) before May 10 at 3:00 p.m.
More information: in this link.
KBBE.2013.1.3.-05: Ecology of drug resistant bacteria and transfer of antimicrobial resistance throughout the food chain.
The previous group experience is in understanding the role of IncH plasmids in Salmonella biology. IncH plasmids are abundant within S. typhi strains (about 50% of them harbor these plasmids) and account for most of the multidrug resistance (MDR) phenotypes of plasmid origin in this microorganism. In the recent past, the group has studied the regulation of the temperature-dependent conjugation of these plasmids, as well as the role of a global modulator encoded by the IncH plasmid R27, the H-NS protein. Recent data, yet unpublished, evidence that these plasmids strongly modify the global transcriptome of the host strain, modifying thus fitness. We propose identifying the modulators that facilitate plasmid-chromosome cross-talk. Interfering with these modulators might thus alter plasmid-chromosome cross-talk and hence reduce fitness of these strains, making them more sensitive to the host defenses, or leading to plasmid loss which, in turn, results in loss of the MDR phenotype.
Vetinnova © 2024